Identification of a divergent genotype of equine arteritis virus from South American donkeys.

A novel equine arteritis virus (EAV) was isolated and sequenced from feral donkeys in Chile. Phylogenetic analysis indicates that the new virus and South African asinine strains diverged at least 100 years from equine EAV strains. The results indicate that asinine strains belonged to a different EAV genotype.

Prevalence of antibodies against equine viral arteritis virus in Northwest, Western Central and North Central Regions of the State of Paraná, Brazil / Prevalência de anticorpos contra o vírus da arterite equina nas mesorregiões Noroeste, Centro Ocidental e Norte Central do Paraná

The prevalence of antibodies against equine viral arteritis virus (EVAV) in healthy horses raised in Northwest, Western Central and North Central regions of the State of Paraná, Brazil was investigated. According to calculated sample size, serum samples of 653 horses were analyzed through standard virus neutralization test. No horse had antibodies to EVAV in Northwest (0/236) and in Western Central (0/99) regions. In North Central region frequency was 0.62% (2/318), with an overall prevalence of 0.30%. It can be concluded that EVA does not represent a problem of epidemiological importance in the studied regions of Paraná.(AU)

O objetivo deste estudo foi investigar a prevalência de anticorpos contra o vírus da arterite viral equina (EVAV) em equinos sadios criados nas mesorregiões Noroeste, Centro Ocidental e Norte Central do estado do Paraná. Após o cálculo do tamanho amostral, foram analisadas, utilizando a técnica de soroneutralização, amostras de soro sanguíneo de 653 equinos. Nenhum animal sororreagente foi encontrado nas mesorregiões Noroeste (0/236) e Centro Ocidental (0/99). Na mesorregião Norte Central a prevalência foi de 0,62% (2/318), totalizando 0,30%. Pode-se concluir que a arterite viral equina (AVE) ainda não representa um problema de importância epidemiológica nos equinos criados nas mesorregiões paranaenses estudadas.(AU)

Prevalência de anticorpos contra o vírus da arterite equina nas mesorregiões Noroeste, Centro Ocidental e Norte Central do Paraná / Prevalence of antibodies against equine viral arteritis virus in Northwest, Western Central and North Central Regions of the State of Paraná, Brazil

O objetivo deste estudo foi investigar a prevalência de anticorpos contra o vírus da arterite viral equina (EVAV) em equinos sadios criados nas mesorregiões Noroeste, Centro Ocidental e Norte Central do estado do Paraná. Após o cálculo do tamanho amostral, foram analisadas, utilizando a técnica de soroneutralização, amostras de soro sanguíneo de 653 equinos. Nenhum animal sororreagente foi encontrado nas mesorregiões Noroeste (0/236) e Centro Ocidental (0/99). Na mesorregião Norte Central a prevalência foi de 0,62% (2/318), totalizando 0,30%. Pode-se concluir que a arterite viral equina (AVE) ainda não representa um problema de importância epidemiológica nos equinos criados nas mesorregiões paranaenses estudadas.(AU)

The prevalence of antibodies against equine viral arteritis virus (EVAV) in healthy horses raised in Northwest, Western Central and North Central regions of the State of Paraná, Brazil was investigated. According to calculated sample size, serum samples of 653 horses were analyzed through standard virus neutralization test. No horse had antibodies to EVAV in Northwest (0/236) and in Western Central (0/99) regions. In North Central region frequency was 0.62% (2/318), with an overall prevalence of 0.30%. It can be concluded that EVA does not represent a problem of epidemiological importance in the studied regions of Paraná.(AU)

Prevalence of antibodies against equine viral arteritis virus in Northwest, Western Central and North Central Regions of the State of Paraná, Brazil / Prevalência de anticorpos contra o vírus da arterite equina nas mesorregiões Noroeste, Centro Ocidental e Norte Central do Paraná

The prevalence of antibodies against equine viral arteritis virus (EVAV) in healthy horses raised in Northwest, Western Central and North Central regions of the State of Paraná, Brazil was investigated. According to calculated sample size, serum samples of 653 horses were analyzed through standard virus neutralization test. No horse had antibodies to EVAV in Northwest (0/236) and in Western Central (0/99) regions. In North Central region frequency was 0.62% (2/318), with an overall prevalence of 0.30%. It can be concluded that EVA does not represent a problem of epidemiological importance in the studied regions of Paraná.

O objetivo deste estudo foi investigar a prevalência de anticorpos contra o vírus da arterite viral equina (EVAV) em equinos sadios criados nas mesorregiões Noroeste, Centro Ocidental e Norte Central do estado do Paraná. Após o cálculo do tamanho amostral, foram analisadas, utilizando a técnica de soroneutralização, amostras de soro sanguíneo de 653 equinos. Nenhum animal sororreagente foi encontrado nas mesorregiões Noroeste (0/236) e Centro Ocidental (0/99). Na mesorregião Norte Central a prevalência foi de 0,62% (2/318), totalizando 0,30%. Pode-se concluir que a arterite viral equina (AVE) ainda não representa um problema de importância epidemiológica nos equinos criados nas mesorregiões paranaenses estudadas.

Antiviral activity of a Bacillus sp. P34 peptide against pathogenic viruses of domestic animals.

P34 is an antimicrobial peptide produced by a Bacillus sp. strain isolated from the intestinal contents of a fish in the Brazilian Amazon basin with reported antibacterial activity. The aim of this work was to evaluate the peptide P34 for its in vitro antiviral properties against canine adenovirus type 2 (CAV-2), canine coronavirus (CCoV), canine distemper virus (CDV), canine parvovirus type 2 (CPV-2), equine arteritis virus (EAV), equine influenza virus (EIV), feline calicivirus (FCV) and feline herpesvirus type 1 (FHV-1). The results showed that the peptide P34 exhibited antiviral activity against EAV and FHV-1. The peptide P34 inhibited the replication of EAV by 99.9% and FHV-1 by 94.4%. Virucidal activity was detected only against EAV. When P34 and EAV were incubated for 6 h at 37 °C the viral titer reduced from 10(4.5) TCID50 to 10(2.75) TCID50, showing a percent of inhibition of 98.6%. In conclusion, our results demonstrated that P34 inhibited EAV and FHV-1 replication in infected cell cultures and it showed virucidal activity against EAV. Since there is documented resistance to the current drugs used against herpesviruses and there is no treatment for equine viral arteritis, it is advisable to search for new antiviral compounds to overcome these infections.

Antiviral activity of a Bacillus sp: P34 peptide against pathogenic viruses of domestic animals

P34 is an antimicrobial peptide produced by a Bacillus sp. strain isolated from the intestinal contents of a fish in the Brazilian Amazon basin with reported antibacterial activity. The aim of this work was to evaluate the peptide P34 for its in vitro antiviral properties against canine adenovirus type 2 (CAV-2), canine coronavirus (CCoV), canine distemper virus (CDV), canine parvovirus type 2 (CPV-2), equine arteritis virus (EAV), equine influenza virus (EIV), feline calicivirus (FCV) and feline herpesvirus type 1 (FHV-1). The results showed that the peptide P34 exhibited antiviral activity against EAV and FHV-1. The peptide P34 inhibited the replication of EAV by 99.9% and FHV-1 by 94.4%. Virucidal activity was detected only against EAV. When P34 and EAV were incubated for 6 h at 37 °C the viral titer reduced from 10(4.5) TCID50 to 10(2.75) TCID50, showing a percent of inhibition of 98.6%. In conclusion, our results demonstrated that P34 inhibited EAV and FHV-1 replication in infected cell cultures and it showed virucidal activity against EAV. Since there is documented resistance to the current drugs used against herpesviruses and there is no treatment for equine viral arteritis, it is advisable to search for new antiviral compounds to overcome these infections.

Antiviral activity of a Bacillus sp: P34 peptide against pathogenic viruses of domestic animals

P34 is an antimicrobial peptide produced by a Bacillus sp. strain isolated from the intestinal contents of a fish in the Brazilian Amazon basin with reported antibacterial activity. The aim of this work was to evaluate the peptide P34 for its in vitro antiviral properties against canine adenovirus type 2 (CAV-2), canine coronavirus (CCoV), canine distemper virus (CDV), canine parvovirus type 2 (CPV-2), equine arteritis virus (EAV), equine influenza virus (EIV), feline calicivirus (FCV) and feline herpesvirus type 1 (FHV-1). The results showed that the peptide P34 exhibited antiviral activity against EAV and FHV-1. The peptide P34 inhibited the replication of EAV by 99.9% and FHV-1 by 94.4%. Virucidal activity was detected only against EAV. When P34 and EAV were incubated for 6 h at 37 °C the viral titer reduced from 10(4.5) TCID50 to 10(2.75) TCID50, showing a percent of inhibition of 98.6%. In conclusion, our results demonstrated that P34 inhibited EAV and FHV-1 replication in infected cell cultures and it showed virucidal activity against EAV. Since there is documented resistance to the current drugs used against herpesviruses and there is no treatment for equine viral arteritis, it is advisable to search for new antiviral compounds to overcome these infections.

Frequency of equine viral arteritis in Minas Gerais State, Brazil / Freqüência da arterite viral eqüina no estado de Minas Gerais, Brasil

Verificou-se a freqüência e a distribuição de eqüídeos soropositivos para arterite viral eqüina (AVE) em 10 Delegacias Regionais do IMA no estado de Minas Gerais, por meio da técnica soroneutralização. A taxa de animais reagentes foi 0,85 por cento (7/826) e em cada Delegacia Regional: Almenara (0,77 por cento), Montes Claros (1,09 por cento), Oliveira (2,12 por cento), São Gonçalo do Sapucaí (2,22 por cento), Teófilo Otoni (1,36 por cento) e Viçosa (1,72 por cento). O presente estudo indica a presença de animais soropositivos para AVE em diferentes regiões do estado de Minas Gerais(AU)

Frequency of equine viral arteritis in Minas Gerais State, Brazil

Verificou-se a freqüência e a distribuição de eqüídeos soropositivos para arterite viral eqüina (AVE) em 10 Delegacias Regionais do IMA no estado de Minas Gerais, por meio da técnica soroneutralização. A taxa de animais reagentes foi 0,85 por cento (7/826) e em cada Delegacia Regional: Almenara (0,77 por cento), Montes Claros (1,09 por cento), Oliveira (2,12 por cento), São Gonçalo do Sapucaí (2,22 por cento), Teófilo Otoni (1,36 por cento) e Viçosa (1,72 por cento). O presente estudo indica a presença de animais soropositivos para AVE em diferentes regiões do estado de Minas Gerais

Prevalência de anticorpos antivírus da arterite dos eqüinos em cavalos criados no Estado de São Paulo / Prevalence of equine arteritis virus specific antibodies in horses of São Paulo State, Brazil

Utilizou-se a prova de soroneutralização em microplacas para detecção de anticorpos antivírus da arterite dos eqüinos em 659 amostras de soro sangüíneo de animais criados no Estado de São Paulo. A prevalência de anticorpos na população estudada foi igual a 18,2%. A raça Mangalarga foi a que apresentou maior taxa de prevalência, 33,3%. Animais na faixa etária de 6 a 24 meses de idade apresentaram a maior taxa de prevalência, 30,4%, e as fêmeas apresentaram prevalência de 22, 9%, mais alta do que nos machos.(AU)

With the purpose of studying the prevalence of equine viral arteritis in horses raised in São Paulo State, Brazil, by the standard microtiter serum neutralization test, 659 serum samples were investigated. The prevalence of antibodies in the horse population was 18.2%, which was significantly higher in Mangalarga horses (33.3%) than in any other breed (Thoroughbred, Arab, Quarter Horse, mixed breeds and others). The distribuition of horses by age showed that horses between 6 to 24 months of age (30.4%) had a higher prevalence (30.4%) rate than others. The female horses prevalence rate of 22.9% was significantly higher than in male horses.(AU)